Written Question · S7W-02184 · Session 7
What discussions it has had with NHS Scotland and NHS boards regarding increasing the availability of fractional exhaled nitric oxide testi…
The question
To ask the Scottish Government what discussions it has had with NHS Scotland and NHS boards regarding increasing the availability of fractional exhaled nitric oxide testing for asthma in primary and secondary care settings, and whether additional funding would be required to enable such an increase.
The answer
Scotland’s National Severe Asthma Pathway was launched earlier this year and shared with all NHS Boards. The pathway supports early identification and management of severe asthma across NHS Scotland. It includes primary care use of fractional exhaled nitric oxide (FeNO) for diagnostics and referral to secondary care. The Centre for Sustainable Delivery are working with Health Boards to support implementation.The Scottish Government will continue to consider opportunities to engage with relevant stakeholders on developments in respiratory care and diagnostic services.Responsibility for planning and delivering local respiratory services, including decisions on the provision of diagnostic equipment and testing pathways, rests with individual NHS Boards.Increasing the availability of FeNO testing would have resource implications, including equipment, workforce and service delivery considerations. Any future funding requirements would need to be considered with NHS Boards and the National Respiratory Programme as part of service planning and implementation of clinical guidance.
In the Official Report
No contribution in the Official Report cites S7W-02184 by reference.